FDA, Covid-19 and vaccine
Digest more
Top News
Overview
Impacts
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.
Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.
The Trump administration plans to drop routine COVID vaccination guidance for kids and pregnant women, marking a major shift in federal health policy, according to a report.
Secretary Robert F. Kennedy Jr., who leads the Department of Health and Human Services, will soon announce the changes to the vaccine schedule.
5d
MedPage Today on MSNCDC to Pull COVID Vax Recommendations; NIH Cut Autism Funding; Florida Bans FluorideKennedy Jr. plans to remove CDC recommendations for COVID-19 vaccination in pregnant women and children. Come the fall, it may just be older adults and people with comorbidities who are urged to get a COVID shot.
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.”